The UAE will ban ciprofloxacin in the veterinary sector from November 1, 2026, under a decision announced by the Emirates Drug Establishment (EDE). The restriction covers nine veterinary products and related raw materials containing the antibiotic. Manufacturers, importers and suppliers must stop dealing in affected products and complete stock withdrawal procedures to help tackle antimicrobial resistance and protect the effectiveness of antibiotics used in human medicine.
- Location: United Arab Emirates
- Authority: Emirates Drug Establishment (EDE)
- Effective date: November 1, 2026
- Who is affected: Veterinary medicine manufacturers, importers, suppliers and relevant establishments
- Business impact: Nine products are affected, including eight imported products and one locally registered product
- What’s next: Businesses must withdraw existing stocks, re-export or dispose of remaining quantities under approved procedures, and submit supporting documents
The UAE will ban the use of ciprofloxacin in veterinary medicines from November 1, 2026, as part of efforts to combat antimicrobial resistance. The Emirates Drug Establishment announced the restriction on October 20, confirming that it covers nine veterinary products and raw materials containing the antibiotic.
The decision means affected businesses must stop manufacturing, importing and supplying the specified products before the new rules take effect. They must also remove existing stocks from the local market and complete the required regulatory procedures.
The restriction focuses on veterinary use. It is not a general ban on ciprofloxacin in human medicine. According to the EDE, the measure aims to protect public health and preserve the effectiveness of antibiotics used to treat bacterial infections.
Why Has the UAE Banned Ciprofloxacin in Veterinary Medicines?
Ciprofloxacin belongs to the fluoroquinolone group of antibiotics. These medicines are important in human healthcare because they are used to treat certain bacterial infections.
The EDE said the decision followed the classification of fluoroquinolones as Critically Important Antimicrobials for human medicine. Inappropriate use of these antibiotics in animals can contribute to bacterial resistance, potentially making some infections harder to treat.
The authority also based its decision on a scientific assessment of antimicrobial resistance data, including studies submitted by United Arab Emirates University.
Antimicrobial resistance develops when bacteria and other microorganisms become less responsive to medicines that previously controlled them. This can limit treatment options and create additional challenges for healthcare providers.
The World Health Organization has warned that misuse and overuse of antibiotics contribute to the growing resistance problem. Responsible use in both human and animal healthcare is therefore important for preserving the effectiveness of existing treatments.
Which Veterinary Products Are Affected by the Ban?
The restriction covers nine veterinary products containing ciprofloxacin. The EDE confirmed that eight are imported products, while one is locally registered.
The decision also applies to raw materials containing ciprofloxacin that are intended for veterinary use.
The authority has identified the affected products and notified relevant establishments about their responsibilities. However, the announcement does not provide a full public list of the nine product names.
Businesses handling affected medicines must take the following steps:
- Stop manufacturing, importing and supplying the restricted products.
- Withdraw existing quantities from the UAE market before November 1, 2026.
- Re-export or dispose of remaining stocks according to approved procedures.
- Submit supporting documents confirming that the required measures have been completed.
The EDE is also preparing a monitoring plan to assess compliance and verify that businesses meet the requirements within the specified timeframe.
What Does the Decision Mean for Veterinary Medicine Businesses?
The November 1 deadline gives affected establishments a limited period to address existing inventory and complete the required paperwork.
Manufacturers, importers and suppliers will need to identify any affected products in their stocks, stop further distribution and arrange for the return, re-export or approved disposal of remaining quantities.
They must also retain and submit the supporting documentation required by the authority. These steps will help the EDE check whether the affected products have been withdrawn from the UAE market.
The announcement does not specify a separate penalty for non-compliance or detail the individual arrangements each business must follow. Establishments handling these medicines should therefore refer to the EDE’s official instructions for their specific obligations.
The restriction also highlights the importance of checking product registrations and regulatory updates when sourcing veterinary medicines. Businesses cannot assume that a product previously available in the UAE can continue to be supplied after the effective date.
How Does the Ban Help Tackle Antimicrobial Resistance?
Antimicrobial resistance is a global health concern because it can reduce the effectiveness of medicines used to treat infections. Resistant bacteria may spread between animals, people and the environment, making responsible antimicrobial use important across different sectors.
The World Organisation for Animal Health (WOAH) recommends responsible and prudent use of antimicrobial medicines in animals. Its guidance emphasises protecting animal health while reducing the risk of resistance developing and spreading.
This approach is often described as One Health, which recognises the links between human, animal and environmental health.
The UAE’s ciprofloxacin restriction is a targeted regulatory measure within this wider effort. Rather than covering every veterinary antibiotic, it focuses on a specific substance considered important to human medicine.
The EDE said the decision is intended to strengthen oversight of veterinary medical products, promote responsible antibiotic use and support national efforts to protect human and animal health.
The UAE’s veterinary ciprofloxacin ban matters because preserving effective antibiotics is important for treating bacterial infections in the future.
For veterinary medicine businesses, the immediate priority is to stop dealing in affected products, withdraw stocks and complete the required documentation before November 1, 2026.
For residents, the decision is part of a broader public health effort to reduce the risks associated with antimicrobial resistance. It does not mean that all veterinary antibiotics are prohibited or that ciprofloxacin has been banned for human patients.
The next step is for the EDE to monitor compliance and verify that the affected establishments have completed the required procedures.
FAQs
When does the UAE’s veterinary ciprofloxacin ban start?
The ban takes effect on November 1, 2026. The Emirates Drug Establishment announced the decision on October 20, 2026.
How many veterinary products are affected?
Nine veterinary products are affected, comprising eight imported products and one locally registered product. The restriction also covers raw materials containing ciprofloxacin intended for veterinary use.
Is ciprofloxacin banned for human use in the UAE?
The announced restriction concerns veterinary use. It does not establish a general ban on ciprofloxacin in human medicine.
What must businesses do before November 1?
Affected establishments must stop manufacturing, importing and supplying the specified products, withdraw existing stocks from the local market, re-export or dispose of remaining quantities under approved procedures, and submit supporting documents.
Why is the UAE restricting this antibiotic in animals?
The EDE said the measure aims to combat antimicrobial resistance and preserve the effectiveness of antibiotics used in human medicine. Inappropriate use of fluoroquinolones in animals could contribute to bacterial resistance.
The UAE’s ciprofloxacin restriction introduces a clear deadline for veterinary medicine businesses handling the nine affected products. From November 1, 2026, the focus will be on preventing further supply, completing stock withdrawals and ensuring compliance with the EDE’s requirements. The measure also reinforces the importance of responsible antibiotic use in protecting human and animal health.
Follow Social Kandura for more updates on local news and things to do in Dubai and across the UAE.
